Palouse Capital Management, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1056516 SPOKANE, WA

Position in REGN

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,545,755

-$257,586 QoQ

Shares Held

2,479

+6.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.17%

of 13F equity value

Holder Rank

#565

of 1,322 holders

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Palouse Capital Management, Inc. holds $1,684,394 across 2 Biotechnology names. REGN ranks #1 (91.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	2,479	$1,545,755
2	INCY	Incyte Corp	1,223	$138,639

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,545,755	2,479	+6.2%	Shares	Sole	2026-07-08
2026-03-31	$1,803,341	2,334	-4.9%	Shares	Sole	2026-04-24
2025-12-31	$1,893,397	2,453	-5.4%	Shares	Sole	2026-01-23
2025-09-30	$1,457,966	2,593	-3.9%	Shares	Sole	2025-10-23
2025-06-30	$1,415,925	2,697	+109.7%	Shares	Sole	2025-08-07
2023-12-31	$1,129,480	1,286	-0.6%	Shares	Sole	2024-01-31
2023-09-30	$1,064,910	1,294	+0.3%	Shares	Sole	2023-10-23
2023-06-30	$926,916	1,290	-5.6%	Shares	Sole	2023-08-09
2023-03-31	$1,122,401	1,366	-22.5%	Shares	Sole	2023-05-15
2022-12-31	$1,271,986	1,763	-23.9%	Shares	Sole	2023-02-17
2022-09-30	$1,595,422	2,316	-2.9%	Shares	Sole	2022-10-21
2022-06-30	$1,409,253	2,384	-20.1%	Shares	Sole	2022-07-28
2022-03-31	$2,084,783	2,985	-3.8%	Shares	Sole	2022-04-21
2021-12-31	$1,959,606	3,103	+19.0%	Shares	Sole	2022-01-25
2021-09-30	$1,578,309	2,608	-30.1%	Shares	Sole	2021-10-21
2021-06-30	$2,083,354	3,730	+1.4%	Shares	Sole	2021-07-28
2021-03-31	$1,741,155	3,680	—	Shares	Sole	2021-05-11
No filing history on record for this holder in this stock.